Full text is available at the source.
Abstract
Essence
A photolabile crRNA dendrimer platform enables light-controlled activation of Cas9 and Cas12a editing.
Evidence
This platform experiment tested a single-site, star-shaped crRNA dendrimer strategy for sequence-independent optical regulation of CRISPR/Cas editing.
Caveat
The abstract reports programmable editing control but does not describe disease models, in vivo testing, or therapeutic safety outcomes.
Simplified